UNICREDIT BANK/CALL/ABBVIE/240/0.1/14.01.26 Share Price

Warrant

DE000HD28MF9

Real-time BOERSE MUENCHEN 11:30:49 30/05/2024 am IST
0.19 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/ABBVIE/240/0.1/14.01.26
Current month-32.14%
1 month-24.00%
Date Price Change
30/24/30 0.19 0.00%
29/24/29 0.19 0.00%
28/24/28 0.19 -5.00%
27/24/27 0.2 0.00%
24/24/24 0.2 -9.09%

Real-time BOERSE MUENCHEN

Last update May 30, 2024 at 11:30 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD28MF
ISINDE000HD28MF9
Date issued 29/01/2024
Strike 240 $
Maturity 14/01/2026 (595 Days)
Parity 10 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.61
Lowest since issue 0.19
Spread 0.02
Spread %10.53%

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
154.8 USD
Average target price
182.1 USD
Spread / Average Target
+17.63%
Consensus